30 kids get trial jabs at Cheluvamba; No vaccine adverse effects observed
Mysore/Mysuru: Hyderabad-based pharmaceutical major Bharat Biotech has begun the clinical trials of its COVID-19 vaccine, Covaxin, on children aged 12-18 years in several parts of the country including Mysuru where children volunteers have started receiving their shots. In Mysuru, the trials are being conducted at Child Rehabilitation Centre of the State-run Cheluvamba Hospital, managed by the Mysore Medical College and Research Institute (MMC&RI).
